Atlas Trials

Can-Fite BioPharma

22 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Can-Fite BioPharma

RecordFirmDate
An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome (NCT07410455)Can-Fite BioPharma2026-06-01
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy (NCT06643260)Can-Fite BioPharma2025-06-01
Namodenoson Treatment of Advanced Pancreatic Cancer (NCT06387342)Can-Fite BioPharma2024-11-10
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis (NCT05201404)Can-Fite BioPharma2023-03-15
Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH) (NCT04697810)Can-Fite BioPharma2021-12-10
Piclidenoson for Treatment of COVID-19 (NCT04333472)Can-Fite BioPharma2021-01-06
Safety &Efficacy of CF101 to Subjects With Uveitis (NCT01905124)Can-Fite BioPharma2019-01-01
A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee (NCT00837291)Can-Fite BioPharma2018-11-01
CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis (NCT03168256)Can-Fite BioPharma2018-09-15
A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease (NCT02927314)Can-Fite BioPharma2017-11-27
CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis (NCT02647762)Can-Fite BioPharma2017-10-30

Track Can-Fite BioPharma automatically

Every clearance here is in the API, with alerts when new ones post.